CD180 functions in activation, survival and cycling of B chronic lymphocytic leukaemia cells

No abstract is available for this paper.

• Publication year

  2011

• Venue

  British Journal of Haematology

• Publication date

  2011-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1365-2141.2011.08605.xPMID 21443749
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Negative regulation of Toll-like receptor signalling].

  2013cited by this paper
• Chronic lymphocytic leukemia

  2011cited by this paper
• Akt is activated in chronic lymphocytic leukemia cells and delivers a pro-survival signal: the therapeutic potential of Akt inhibition

  2010cited by this paper
• Resting Human Memory B Cells Are Intrinsically Programmed for Enhanced Survival and Responsiveness to Diverse Stimuli Compared to Naive B Cells1

  2009cited by this paper
• Molecular mechanism and function of CD40/CD40L engagement in the immune system

  2009cited by this paper
• Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation

  2008cited by this paper
• The role of toll-like receptors

  2008cited by this paper
• Constitutive activation of distinct BCR-signaling pathways in a subset of CLL patients: a molecular signature of anergy.

  2008influential reference
• Toll-like receptors: lessons to learn from normal and malignant human B cells.

  2008cited by this paper
• TLR accessory molecules.

  2008cited by this paper
• Regulation of TLR4 signaling and the host interface with pathogens and danger: the role of RP105

  2007cited by this paper
• Identification of anergic B cells within a wild-type repertoire.

  2006cited by this paper
• Silencing of autoreactive B cells by anergy: a fresh perspective.

  2006cited by this paper
• Expression of toll-like receptors on B lymphocytes.

  2005cited by this paper
• Differential expression of CD180 and IgM by B‐cell chronic lymphocytic leukaemia cells using mutated and unmutated immunoglobulin VH genes

  2005cited by this paper
• Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105

  2005cited by this paper
• Differential effects on CLL cell survival exerted by different microenvironmental elements.

  2005cited by this paper
• Chronic lymphocytic leukemia: revelations from the B-cell receptor.

  2004cited by this paper
• Chronic lymphocytic leukemia : revelations from the B-cell receptor

  2004cited by this paper
• Cytotoxic CD4+ T cells in patients with B cell chronic lymphocytic leukemia kill via a perforin-mediated pathway.

  2004cited by this paper
• CD19 regulates innate immunity by the toll-like receptor RP105 signaling in B lymphocytes.

  2003influential reference
• Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.

  2003cited by this paper
• A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells.

  2003cited by this paper
• In Vivo CD 40-gp 39 Interactions Are Essential for Thymus-dependent Humoral Immunity . I . In Vivo Expression of CD 40 Ligand , Cytokines , and Antibody Production Delineates Sites of Cognate TB Cell Interactions By

  2003cited by this paper
• ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.

  2003cited by this paper
• B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor.

  2003cited by this paper
• IL-4 Biology: Impact on Normal and Leukemic CLL B Cells

  2003cited by this paper
• Requirement for MD-1 in cell surface expression of RP105/CD180 and B-cell responsiveness to lipopolysaccharide.

  2002cited by this paper
• Quantitative Expression of Toll-Like Receptor 1–10 mRNA in Cellular Subsets of Human Peripheral Blood Mononuclear Cells and Sensitivity to CpG Oligodeoxynucleotides1

  2002cited by this paper
• Expression and Production of Interleukin 4 in B-Cell Chronic Lymphocytic Leukaemia

  2001cited by this paper
• Caspase 8 activation independent of Fas (CD95/APO-1) signaling may mediate killing of B-chronic lymphocytic leukemia cells by cytotoxic drugs or gamma radiation.

  2001cited by this paper
• The Toll-like Receptor Protein Rp105 Regulates Lipopolysaccharide Signaling in B Cells

  2000cited by this paper
• Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia.

  1999cited by this paper
• Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.

  1999cited by this paper
• Anti‐human RP105 sera induces lymphocyte proliferation

  1999influential reference
• Unmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia

  1999cited by this paper
• RP105 is associated with MD-1 and transmits an activation signal in human B cells.

  1998influential reference
• Btk/Tec kinases regulate sustained increases in intracellular Ca2+ following B‐cell receptor activation

  1998influential reference
• The Molecular Mechanism of B Cell Activation by toll-like Receptor Protein RP-105

  1998cited by this paper
• Molecular cloning of human RP105

  1997cited by this paper
• Molecular cloning of a human RP105 homologue and chromosomal localization of the mouse and human RP105 genes (Ly64 and LY64).

  1996cited by this paper
• Theophylline synergizes with chlorambucil in inducing apoptosis of B-chronic lymphocytic leukemia cells.

  1996cited by this paper
• IL-4 induces Fas resistance in B cells.

  1996cited by this paper
• Activation mediated by RP105 but not CD40 makes normal B cells susceptible to anti-IgM-induced apoptosis: a role for Fc receptor coligation

  1996cited by this paper
• Bcl-x rather than Bcl-2 mediates CD40-dependent centrocyte survival in the germinal center.

  1996cited by this paper
• RP105, a novel B cell surface molecule implicated in B cell activation, is a member of the leucine-rich repeat protein family.

  1995influential reference
• Murine B cell proliferation and protection from apoptosis with an antibody against a 105-kD molecule: unresponsiveness of X-linked immunodeficient B cells

  1994influential reference
• In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions

  1993cited by this paper
• CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation.

  1992cited by this paper
• Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression

  1992cited by this paper
• Mechanism of antigen-driven selection in germinal centres

  1989cited by this paper
• Activation of human B cells. Comparison of the signal transduced by IL-4 to four different competence signals.

  1989cited by this paper
• Modulation of human polymorphonuclear leukocyte IgG Fc receptors and Fc receptor-mediated functions by IFN-gamma and glucocorticoids.

  1988cited by this paper
• Antibody to a novel 95-kDa surface glycoprotein on human B cells induces calcium mobilization and B cell activation.

  1988cited by this paper
• Activation of human B cell proliferation through surface Bp35 (CD20) polypeptides or immunoglobulin receptors.

  1987cited by this paper
• Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50.

  1986cited by this paper

• The effect of IL-4 on CD180 expression and signalling in Chronic lymphocytic leukaemia (CLL).

  2026cites this paper
• Expression and signaling patterns of CD180/MD-1 and CD150 in Chronic Lymphocytic Leukaemia (CLL) cells.

  2026cites this paper
• G-quadruplex stabilization induces DNA breaks in pericentromeric repetitive DNA sequences in B lymphocytes

  2025cites this paper
• СУЧАСНІ ПІДХОДИ ДО ДІАГНОСТИКИ ТА ПРОГНОЗУВАННЯ ПЕРЕБІГУ ХРОНІЧНОГО ЛІМФОЛЕЙКОЗУ

  2025cites this paper
• CD180 as a Robust Immunophenotypic Marker for Differentiating Lymphoplasmacytic Lymphoma/ Waldenström Macroglobulinemia from Marginal Zone Lymphoma.

  2025cites this paper
• MD-1 downregulation is associated with reduced cell surface CD180 expression in CLL.

  2024cites this paper
• A human gut Faecalibacterium prausnitzii fatty acid amide hydrolase

  2024cites this paper
• GPR40 agonist ameliorates neurodegeneration and motor impairment by regulating NLRP3 inflammasome in Parkinson's disease animal models.

  2024cites this paper
• Empirical Study on Exploring the Role of CD180 and MD-1 Prognostic Indicators for the Chronic Lymphocytic Leukaemia (CLL) Disease.

  2023cites this paper
• The role of CD180 in hematological malignancies and inflammatory disorders

  2023cites this paper
• Ligation of TLR Homologue CD180 of B Cells Activates the PI3K/Akt/mTOR Pathway in Systemic Sclerosis and Induces a Pathological Shift in the Expression of BAFF Receptors

  2022cites this paper
• CD20+CD22+ADAM28+ B Cells in Tertiary Lymphoid Structures Promote Immunotherapy Response

  2022cites this paper
• A new score including CD43 and CD180: Increased diagnostic value for atypical chronic lymphocytic leukemia

  2021cites this paper
• Expression patterns of CD180 in the lymph nodes of patients with chronic lymphocytic leukaemia

  2021cites this paper
• The expression and signalling patterns of CD180 toll like receptor in Chronic Lymphocytic Leukaemia (CLL)

  2019influential citation
• SLAMF1/CD150 in hematologic malignancies: Silent marker or active player?

  2019cites this paper
• CD markers variations in chronic lymphocytic leukemia: New insights into prognosis

  2019cites this paper
• Age-specific biological and molecular profiling distinguishes paediatric from adult acute myeloid leukaemias

  2018cites this paper
• Functional interaction between CD180 Toll-like receptor (TLR) and B cell receptor (BCR) in the biology of Chronic Lymphocytic Leukaemia (CLL)

  2017influential citation
• Rewiring of sIgM-Mediated Intracellular Signaling through the CD180 Toll-like Receptor

  2015cites this paper
• Human CD180 Transmits Signals via the PIM-1L Kinase

  2015cites this paper
• Cell surface phenotype profiles distinguish stable and progressive chronic lymphocytic leukemia

  2014cites this paper
• CD180 expression in B‐cell lymphomas: A multicenter GEIL study

  2014cites this paper
• LRP5 negatively regulates differentiation of monocytes through abrogation of Wnt signalling

  2013cites this paper
• Visualising the Cross-Level Relationships between Pathological and Physiological Processes and Gene Expression: Analyses of Haematological Diseases

  2013cites this paper
• 2.11 Chronic Lymphocytic Leukemia Cells Respond to CD180 Ligation by Alternative Signalling via Akt (PKB) or P38MAPK Pathways

  2011cites this paper
• 2.10 Effect of Sequential Ligation of CD180/RP105 and sIgM on Downstream Signalling in CLL Cells

  2011cites this paper
• Intraclonal Complexity in Chronic Lymphocytic Leukemia: Fractions Enriched in Recently Born/Divided and Older/Quiescent Cells

  2011cites this paper
• 2.9 Pro-Survival Signalling in ‘Responder' CLL Cells After Ligation of CD180

  2011cites this paper